其他
胰腺癌的免疫治疗进展
Ipilimumab
Tremelimumab
▼ 表1
Pembrolizumab
Nivolumab
▼ 表2
▼ 表3
▼ 已公布的胰腺癌ICIs临床研究
1. HenriksenA , Dyhl-Polk A , Chen I , et al. Checkpoint inhibitors in pancreaticcancer[J]. Cancer Treatment Reviews, 2019, 78:17-30.Schizas D, Charalampakis N,Kole C, et al. Immunotherapy for pancreatic cancer: A 2020 update. Cancer Treat
精彩推荐:
- End -